ANTIVIRAL POTENTIAL OF A NEW GENERATION OF ACYCLIC NUCLEOSIDE PHOSPHONATES, THE 6-[2-(PHOSPHONOMETHOXY)ALKOXY]-2,4-DIAMINOPYRIMIDINES

REFERENCES

• De Clercq , E. 2004 . Antiviral drugs in current clinical use . J. Clin. Virol. , 30 : 115 – 133 .
   PubMed Web of Science ®Google Scholar
• De Clercq , E. 2003 . Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections . Clin. Microbiol. Rev. , 16 : 569 – 596 .
   PubMed Web of Science ®Google Scholar
• De Clercq , E. 2003 . Potential of acyclic nucleoside phosphonates in the treatment of DNA virus and retrovirus infections . Expert Rev. Anti-infect. Ther. , 1 : 21 – 43 .
   PubMedGoogle Scholar
• Gallant , J. E. , Staszewski , S. , Pozniak , A. L. , DeJesus , E. , Suleiman , J. M. , Miller , M. D. , Coakley , D. F. , Lu , B. , Toole , J. J. , Cheng , A. K. and 903 Study Group . 2004 . Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naïve patients: a 3-year randomized trial . JAMA , 292 : 191 – 201 .
   PubMed Web of Science ®Google Scholar
• van Bömmel , F. , Wünsche , T. , Schürmann , D. and Beck , T. 2002 . Tenofovir treatment in patients with lamivudine-resistant hepatitis B mutants strongly affects viral replication . Hepatology , 36 : 507 – 508 .
   PubMed Web of Science ®Google Scholar
• Quenelle , D. C. , Collins , D. J. , Wan , W. B. , Beadle , J. R. , Hostetler , K. Y. and Kern , E. R. 2004 . Oral treatment of cowpox and vaccinia virus infections in mice with ether lipid esters of cidofovir . Antimicrob. Agents Chemother. , 48 : 404 – 412 .
   PubMed Web of Science ®Google Scholar
• Buller , R. M. , Owens , G. , Schriewer , J. , Melman , L. , Beadle , J. R. and Hostetler , K. Y. 2004 . Efficacy of oral active ether lipid analogs of cidofovir in a lethal mousepox model . Virology , 318 : 474 – 481 .
   PubMed Web of Science ®Google Scholar
• Holý , A. , Votruba , I. , Masojídková , M. , Andrei , G. , Snoeck , R. , Naesens , L. , De Clercq , E. and Balzarini , J. 2002 . 6-[2-(Phosphonomethoxy)alkoxy]pyrimidines with antiviral activity . J. Med. Chem. , 45 : 1918 – 1929 .
   PubMed Web of Science ®Google Scholar
• Balzarini , J. , Pannecouque , C. , De Clercq , E. , Aquaro , S. , Perno , C.-F. , Egberink , H. and Holý , A. 2002 . Antiretrovirus activity of a novel class of acyclic pyrimidine nucleoside phosphonates . Antimicrob. Agents Chemother. , 46 : 2185 – 2193 .
   PubMed Web of Science ®Google Scholar
• Hocková , D. , Holý , A. , Masojídková , M. , Andrei , G. , Snoeck , R. , De Clercq , E. and Balzarini , J. 2003 . 5-substituted-2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]pyrimidines – acyclic nucleoside phosphonate analogues with antiviral activity . J. Med. Chem. , 46 : 5064 – 5073 .
   PubMed Web of Science ®Google Scholar
• Hocková , D. , Holý , A. , Masojidková , M. , Andrei , G. , Snoeck , R. , De Clercq , E. and Balzarini , J. 2004 . Synthesis and antiviral activity of 2,4-diamino-5-cyano-6-[2-(phosphonomethoxy)ethoxy]pyrimidine and related compounds . Bioorg. Med. Chem. , 12 : 3197 – 3202 .
   PubMed Web of Science ®Google Scholar
• Balzarini , J. , Pannecouque , C. , Naesens , L. , Snoeck , R. , De Clercq , E. , Hocková , D. and Holý , A. 2004 . 6-[2-(Phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines: a new class of acyclic pyrimidine nucleoside phosphonates with antiviral activity . Nucleosides Nucleotides Nucleic Acids , 23 : 243 – 249 .
   Web of Science ®Google Scholar
• Ying , C. , Holý , A. , Hocková , D. , De Clercq , E. and Neyts , J. 2004 . Novel acyclic nucleoside phosphonate analogues as potent and selective anti-HBV agents . 17th International Conference on Antiviral Research . May 2–6 2004 , Tucson, Arizona, USA. A45 Antivir. Res. 62(45)
   Google Scholar
• Ying , C. , Hocková , D. , Holý , A. , De Clercq , E. and Neyts , J. 2004 . Novel acyclic nucleoside phosphonate analogues with potent and selective anti-hepatitis B virus activity . Antimicrob. Agents Chemother. , submitted for publication
   Web of Science ®Google Scholar
• De Clercq , E. , Holý , A. , Rosenberg , I. , Sakuma , T. , Balzarini , J. and Maudgal , P. C. 1986 . A novel selective broad-spectrum anti-DNA virus agent . Nature , 323 : 464 – 467 .
   PubMed Web of Science ®Google Scholar
• Naesens , L. , Lenaerts , L. , Holý , A. , Balzarini , J. and De Clercq , E. 2004 . Activity of different classes of nucleoside and nucleotide analogues against adenovirus in cell culture . 17th International Conference on Antiviral Research . May 2–6 2004 , Tucson, Arizona, USA. A74 Antivir. Res. 62(117)
   Google Scholar
• Andrei , G. , Holý , A. , Dal Pozzo , F. , Scagliarini , A. , De Clercq , E. and Snoeck , R. 2004 . Activity of novel acyclic pyrimidine nucleoside phosphonates against poxviruses. 17th international conference on antiviral research, Tucson, Arizona, USA, 2–6 May 2004 . Antivir. Res. , 62 ( 106 ) : A70
   Google Scholar
• Neyts , J. , Leyssen , P. , Verbeken , E. and De Clercq , E. 2004 . Efficacy of cidofovir in a murine model for disseminated/progressive vaccinia . Antimicrob. Agents Chemother. , 48 : 2267 – 2273 .
   PubMed Web of Science ®Google Scholar
• De Clercq , E. and Neyts , J. 2004 . Therapeutic potential of nucleoside/nucleotide analogues against poxvirus infections . Rev. Med. Virol. , 14 : 289 – 300 .
   PubMed Web of Science ®Google Scholar
• Neyts , J. , Leyssen , P. , De Clercq , E. and Holý , A. 2004 . Effects of (S)-HPMPDAP and (S)-HPMPO-DAPym on vaccinia virus infections in mice . 17th International Conference on Antiviral Research . May 2–6 2004 , Tucson, Arizona, USA. pp. A71 Antivir. Res. 62(109)
   Google Scholar
• Dal Pozzo , F. , Holý , A. , Van Den Oord , J. , Snoeck , R. , De Clercq , E. and Andrei , G. 2004 . Activity of Acyclic Nucleoside Phosphonates Against Orf Virus In Vitro and Ex Vivo . XVth International Poxvirus and Iridovirus Conference . September 3–8 2004 , Oxford, United Kingdom.
   Google Scholar
• Andrei , G. , Van Den Oord , J. , Wolfgang , G. , Lee , W. , De Clercq , E. and Snoeck , R. 2004 . Efficacy of PMEG [9-(2-phosphonylmethoxyethyl)guanine] and its prodrug cPr-PMEDAP [9-(2-phosphonylmethoxyethyl)-N6-cyclo-propyl-2,6-diaminopurine in organotypic cultures of normal and papillomavirus ((HPV)-positive keratino-cytes, 17th International Conference on Antiviral Research, Tucson, Arizona, USA, 2 May–6 May 2004 . Antivir. Res. , 62 ( 84 ) : A61
   Google Scholar